Gufic BioSciences Ltd

Gufic BioSciences Ltd Share Price Today: Live Updates & Key Insights

Get insights on Gufic BioSciences Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.

Gufic BioSciences Ltd Share Price Chart

Gufic BioSciences Ltd Fundamentals

Traded Volume: 1,47,244

Market Cap(Cr): 3,534

Avg Traded Price 350.46

1 Year return -13.10%

Upper Circuit 354.5

Lower Circuit 339.5

P/E TTM 62.00

P/B Ratio 6.00

Traded Value(Cr) 518.96

EPS TTM 5.676

Book value 5.676

Dividend 0.00%

Gufic BioSciences Ltd Share Price Performance

Shows the percentage change in stock price over different time periods

This section highlights Gufic BioSciences Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Gufic BioSciences Ltd share price history, short-term movements, long-term trends, and overall investor sentiment

1W +8.58%

1M +0.53%

3M -6.18%

1Y -13.10%

YTD -24.95%

Gufic BioSciences Ltd Traded Volume Movement

Shows the trading volume over different time periods

This section highlights Gufic BioSciences Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment

Yesterday 1.99L

Day Before Yesterday 1.51L

1W Avg 1.37L

1M Avg 69507.57

3M Avg 58176.19

Gufic BioSciences Ltd Technical Details

Gufic BioSciences Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.

Support 1 343

Support 2 334

Support 3 328

Pivot Point : 349

Resistance 1 358

Resistance 2 364

Resistance 3 373

Gufic BioSciences Ltd Corporate Actions

Gufic BioSciences Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Gufic BioSciences Ltd’s capital allocation strategies.

All

Ex-Date 22-Sep-2025 Type D Description 0.10/share@10.00% Record Date 22-Sep-2025 Ratio 10.00

Ex-Date 17-Sep-2024 Type D Description 0.10/share@10.00% Record Date - Ratio 10.00

Ex-Date 21-Sep-2023 Type D Description 0.10/share@10.00% Record Date 21-Sep-2023 Ratio 10.00

Ex-Date 24-Aug-2022 Type D Description 0.10/share@10.00% Record Date 25-Aug-2022 Ratio 10.00

Ex-Date 09-Sep-2021 Type D Description 0.10/share@10.00% Record Date - Ratio 10.00

Ex-Date 03-Nov-2020 Type D Description 0.05/share@5.00% Record Date - Ratio 5.00

Ex-Date 20-Sep-2019 Type D Description 0.05/share@5.00% Record Date - Ratio 5.00

Ex-Date 19-Sep-2018 Type D Description 0.05/share@5.00% Record Date - Ratio 5.00

Ex-Date 28-Aug-2017 Type D Description 0.05/share@5.00% Record Date - Ratio 5.00

Ex-Date 19-Sep-2016 Type D Description 0.05/share@5.00% Record Date - Ratio 5.00

Ex-Date 22-Sep-2015 Type D Description 0.05/share@5.00% Record Date - Ratio 5.00

Ex-Date 18-Sep-2014 Type D Description 0.05/share@5.00% Record Date - Ratio 5.00

Ex-Date 02-Sep-2013 Type D Description 0.05/share@5.00% Record Date - Ratio 5.00

Ex-Date 16-Aug-2012 Type D Description 0.05/share@5.00% Record Date - Ratio 5.00

Ex-Date 16-Sep-2011 Type D Description 0.05/share@5.00% Record Date - Ratio 5.00

Ex-Date 20-Sep-2010 Type D Description 0.05/share@5.00% Record Date - Ratio 5.00

Ex-Date 17-Sep-2009 Type D Description 0.05/share@5.00% Record Date - Ratio 5.00

Ex-Date 11-Dec-2008 Type D Description 0.05/share@5.00% Record Date - Ratio 5.00

Ex-Date 19-Mar-2008 Type D Description 0.05/share@5.00% Record Date - Ratio 5.00

Dividends

Announcement Date 22-Sep-2025 Ex Dividend Date 22-Sep-2025 Dividend(%) 10

Announcement Date 17-Sep-2024 Ex Dividend Date 17-Sep-2024 Dividend(%) 10

Announcement Date 21-Sep-2023 Ex Dividend Date 21-Sep-2023 Dividend(%) 10

Announcement Date 24-Aug-2022 Ex Dividend Date 24-Aug-2022 Dividend(%) 10

Announcement Date 09-Sep-2021 Ex Dividend Date 09-Sep-2021 Dividend(%) 10

Announcement Date 03-Nov-2020 Ex Dividend Date 03-Nov-2020 Dividend(%) 5

Announcement Date 20-Sep-2019 Ex Dividend Date 20-Sep-2019 Dividend(%) 5

Announcement Date 19-Sep-2018 Ex Dividend Date 19-Sep-2018 Dividend(%) 5

Announcement Date 28-Aug-2017 Ex Dividend Date 28-Aug-2017 Dividend(%) 5

Announcement Date 19-Sep-2016 Ex Dividend Date 19-Sep-2016 Dividend(%) 5

Announcement Date 22-Sep-2015 Ex Dividend Date 22-Sep-2015 Dividend(%) 5

Announcement Date 18-Sep-2014 Ex Dividend Date 18-Sep-2014 Dividend(%) 5

Announcement Date 02-Sep-2013 Ex Dividend Date 02-Sep-2013 Dividend(%) 5

Announcement Date 16-Aug-2012 Ex Dividend Date 16-Aug-2012 Dividend(%) 5

Announcement Date 16-Sep-2011 Ex Dividend Date 16-Sep-2011 Dividend(%) 5

Announcement Date 20-Sep-2010 Ex Dividend Date 20-Sep-2010 Dividend(%) 5

Announcement Date 17-Sep-2009 Ex Dividend Date 17-Sep-2009 Dividend(%) 5

Announcement Date 11-Dec-2008 Ex Dividend Date 11-Dec-2008 Dividend(%) 5

Announcement Date 19-Mar-2008 Ex Dividend Date 19-Mar-2008 Dividend(%) 5

Bonus

No Bonus has been declared by GUFICBIO

Splits

No Split has been declared by GUFICBIO

Others

Rights No Rights has been declared by GUFICBIO

Gufic BioSciences Ltd Peer Comparison

Shows key financial metrics for the company and its peers

This section compares Gufic BioSciences Ltd with leading peers in the banking sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Gufic BioSciences Ltd's relative performance and valuation against major competitors.

Stock Name Senores Pharmaceuticals Ltd ₹819.55 (-0.75%) M. Cap (Cr) 37.74 1 Yr Return (%) NaN% P/E (TTM) 43.32 PB Ratio 4.80

Stock Name Dishman Carbogen Amcis Ltd ₹237.95 (-3.33%) M. Cap (Cr) 37.31 1 Yr Return (%) +8.89% P/E (TTM) 27.35 PB Ratio 0.65

Stock Name RPG Life Sciences Ltd ₹2254.00 (+1.30%) M. Cap (Cr) 37.28 1 Yr Return (%) +10.91% P/E (TTM) 17.31 PB Ratio 9.83

Stock Name Gufic BioSciences Ltd ₹352.45 (+2.86%) M. Cap (Cr) 35.34 1 Yr Return (%) -13.10% P/E (TTM) 62.10 PB Ratio 6.16

Stock Name Unichem Laboratories Ltd ₹466.40 (-2.48%) M. Cap (Cr) 32.84 1 Yr Return (%) -45.80% P/E (TTM) 37.12 PB Ratio 1.34

Stock Name Hikal Ltd ₹224.98 (-1.46%) M. Cap (Cr) 27.74 1 Yr Return (%) -41.82% P/E (TTM) 274.66 PB Ratio 2.20

Stock Name IOL Chemicals & Pharmaceuticals Ltd ₹90.32 (-1.42%) M. Cap (Cr) 26.51 1 Yr Return (%) +32.14% P/E (TTM) 22.88 PB Ratio 1.60

Gufic BioSciences Ltd Cash Flow

Cash flow data provides a view of how money is generated and spent by Gufic BioSciences Ltd, across its operating activities, investing activities, and financing activities.

PARTICULARS Operating Activities Mar 2025 122.78 Mar 2024 -7.46 Mar 2023 -26.59 Mar 2022 104.44 Mar 2021 89.06

PARTICULARS Investing Activities Mar 2025 -71.79 Mar 2024 -102.40 Mar 2023 -190.73 Mar 2022 -95.94 Mar 2021 -8.51

PARTICULARS Financing Activities Mar 2025 -37.20 Mar 2024 82.38 Mar 2023 234.31 Mar 2022 -3.10 Mar 2021 -78.62

PARTICULARS Net Cash Flow Mar 2025 13.78 Mar 2024 -27.48 Mar 2023 16.99 Mar 2022 5.41 Mar 2021 1.94

Gufic BioSciences Ltd Shareholding Pattern

This shows the ownership breakdown of Gufic BioSciences Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.

Promoter 72.5%

Public 23.51%

Other Institutions 0.18%

FII 0.33%

Mutual Funds 3.48%

About Gufic BioSciences Ltd

Gufic Biosciences Limited is a prominent global pharmaceutical enterprise dedicated to delivering a broad spectrum of pharmaceutical services to its clients. Renowned for its extensive range of pharmaceutical products, Gufic operates as a comprehensive solution provider in both domestic and international markets, supported by a robust distribution network. The Company is ranked among the top 100 pharmaceutical companies in India.Gufic is a leading manufacturer of lyophilized injections in India, with a state-of-the-art automated lyophilization plant located in Navsari, Gujarat. The Company was incorporated in July, 1984. The recent addition of the Indore manufacturing facility has further solidified Gufic's position as one of the world's largest producers of lyophilized injections. These products cover therapeutic areas, including antibiotics, antifungals, cardiac medications, infertility treatments, antiviral solutions, and proton pump inhibitors (PPIs).The Company made a reverse merger of itself with Central Finance. The promoters of GBL took over Central Finance at Rs 40-42 per share and then got GBL listed on BSE. Presently, the Company is engaged in the manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services. The Choksi and Gandhi family, the promoters of GBL, have a long-standing presence in the pharma industry. In 1960, the family set up a joint venture company called Lyka Labs. In 1976, they decided to part ways and the Choksi family took over the manufacturing facility and the Gufic group of companies was born. Initially known as Gujarat Fine Chemicals, the first foray of the Gufic group was in the manufacture of various bulk drugs. The company later entered the formulation market. Currently, the overall profile of GBL comprises ethical products, herbal products, consumer products and bulk drugs that are sold in the domestic and the international markets. Over the past several years, the company have a known reputation of creating brands that have vaulted to leadership positions in the category in which they have been marketed. To mention a few names: Shapers (sanitary napkins), Onergy, and Stretch nil.In the year 2000, the company issued Bonus Equity Shares in proportion of five Equity shares for every two Equity shares held.Gufic has divested brands in the ethical pharma business in a seller's market. The company plan to invest further in R&D activities and aggressively enter the herbal product and consumer product segments, where it foresee a huge potential. While benefiting from the rich, traditional knowledge base in India, it would like to operate from an area of strength in the herbal products segment.In 2020-21, Gufic Lifesciences Private Limited amalgamated with the Company through the Scheme of Amalgamation which became effective from May 21, 2021. GUFIC UK LIMITED (GUL), a wholly owned subsidiary of the Company, was incorporated in United Kingdom on March 15, 2022. Similarly, in 2023, Gufic Ireland Limited (GIL) was incorporated on March 02, 2023.

Chairman & Managing Director

Jayesh P Choksi

Registered office Shop-37 1st Flr Kamala Bhavan, Swami Nityanand Road Andheri(E, Mumbai, Maharashtra, 400069

FAX :91-022-66919187/67261007/66919189

Background

Incorporation Year 1984

Face Value ₹1.00

Market Lot 1

Gufic BioSciences Ltd Latest News

VIEW MORE NEWS

FAQs on Gufic BioSciences Ltd